Subscribe To
bellicum (blcm) down on ending development of car-t candidates
Following the decision to discontinue the development of pipeline candidates, bellicum Pharmaceuticals ...
March 16, 2023, 1:00 pm
Is bellicum pharmaceuticals (blcm) outperforming other medical stocks this year?
Here is how bellicum Pharmaceuticals (BLCM) and Castle Biosciences, Inc. (CSTL) have performed compared...
February 27, 2023, 11:17 am
Correction — bellicum reports inducement grants under nasdaq listing rule 5635(c)(4)
HOUSTON, Jan. 31, 2023 (GLOBE NEWSWIRE) — In a release issued earlier today by bellicum Pharmaceutica...
January 31, 2023, 11:43 pm
bellicum announces presentation by unc at ash 2022 on potential abrogation of ic9 car t-cell toxicities with rimiducid
HOUSTON, Dec. 11, 2022 (GLOBE NEWSWIRE) — bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in ...
December 11, 2022, 3:00 pm